| Bid Price | 2016.00p | High Price | 2012.00p |
|---|
| Ask Price | 2018.00p | Low Price | 1978.00p |
|---|
| Open Price | 2006.00p | Spread | 0.10% |
|---|
| Prev Close | 2010.00p | Volume | 441,914 |
|---|
Hikma Pharmaceuticals PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Mar 26, 2025 | 2008.00 | 2026.00 | 1994.00 | 2010.00 | 637,045 |
| Mar 25, 2025 | 2000.00 | 2034.00 | 1978.00 | 2006.00 | 618,017 |
| Mar 24, 2025 | 2030.00 | 2030.00 | 1982.00 | 1986.00 | 424,902 |
| Mar 21, 2025 | 2018.00 | 2028.00 | 2006.00 | 2020.00 | 843,794 |
| Mar 20, 2025 | 2044.00 | 2050.00 | 2008.00 | 2022.00 | 645,564 |
Hikma Pharmaceuticals PLC Information
| Name | Hikma Pharmaceuticals PLC | Index | FTSE 100 |
|---|
| ISIN | GB00B0LCW083 | Epic | HIK |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | SET1 |
|---|
| Industry | Drug Manufacturers - Specialty & Generic | Sector | Healthcare |
|---|
| EMS | 500 | Trading Status | Closed |
|---|
| Shares in Issue | 221.89 m | Prev Close | 2010.00p |
|---|
| PE Ratio | 30.608742 | Market Cap | £4.43 bn |
|---|
| Div Yield | 3.04 | Div per Share | $0.25 |
|---|
| EPS | $0.26 | Div Cover | 1.0288 |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | 0.022281 | DPS Growth (%) | 0.1711 |
|---|
| Current Ratio | 1.568335 | Quick Ratio | 0.760269 |
|---|
Hikma Pharmaceuticals PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 04/03/25 | TIN | Mazen Darwazah | CH | 14,844 @ £0.00 | £0.00 |
| 04/03/25 | TIN | Said Darwazah | CEO | 18,420 @ £0.00 | £0.00 |
| 04/03/25 | EXR | Riad Mishlawi | CEO | 19,890 @ £0.00 | £0.00 |
| 04/03/25 | TIN | Riad Mishlawi | CEO | 18,691 @ £0.00 | £0.00 |
| 24/09/24 | DRIP | Riad Mishlawi | CEO | 509 @ £19.03 | £9,686.00 |
| 09/05/24 | DRIP | Riad Mishlawi | CEO | 736 @ £19.79 | £14,565.00 |
| 13/03/24 | TIN | Mazen Darwazah | CH | 26,812 @ £0.00 | £0.00 |
| 13/03/24 | TIN | Mazen Darwazah | CH | 13,903 @ £0.00 | £0.00 |
| 13/03/24 | TIN | Said Darwazah | CEO | 34,652 @ £0.00 | £0.00 |
| 13/03/24 | TIN | Said Darwazah | CEO | 19,830 @ £0.00 | £0.00 |
Hikma Pharmaceuticals PLC News
